Health Care

Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why

What's Going On With UroGen Pharma Stock Wednesday?

Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why

What's Going On With UroGen Pharma Stock Wednesday?

EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND

Frank Bisignano Had To Google Social Security When He First Got A Call For The Job: 'What The Heck's The Commissioner…'

EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND

Frank Bisignano Had To Google Social Security When He First Got A Call For The Job: 'What The Heck's The Commissioner…'

RFK Jr.'s 'Make America Healthy Again' Report Stirs GOP, Farmers Over Glyphosate Concerns Ahead Of Release

House Advances Trump's 'One Big Beautiful Bill' After Key Medicaid, Tax, And Border Security Changes

Health Care Recent News

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults.

Trump's Tax Bill Expands Child Benefits With $2,500 Credit And $1,000 Savings Boost For Babies Born Through 2028

Trump's proposed 1,000-page bill could increase tax credits for parents and introduce savings accounts for children.

Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal

Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.'s bispecific antibody SSGJ-707.

Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses

Trump's sweeping tax-and-spending bill stirs markets, boosts defense, hits clean energy, and expands debt.

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.

GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst

J.P. Morgan analyst revises outlook on GoodRx Holdings following Q1 earnings, reaffirms Overweight rating and $7 price target.

EXCLUSIVE: UnitedHealth Gets Dumped, Why This Asset Manager Says Insurer Is No Longer A Safe Bet

Asset manager dumps UNH stock, citing deterioration in fundamentals and turns to innovation-driven segments and global insurance firms. The focus now is on innovation, not incumbency.

EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results

GTBP announces completion of dosing in Cohort 1 and start of dosing in Cohort 2 of Phase 1 trial for GTB-3650, showing potential for NK cell expansion and increased immunologic activity. Detailed results to be released in 2025. GTBP stock up 0.90%.

Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health conditions that increase risk of severe illness.

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.

UnitedHealth CEO, Other Insiders Buy Millions In Stock As It Sinks Over 23% In A Week: Move Gets 'Mixed' Reaction

As shares of UnitedHealth Group Inc. (NYSE: UNH) witness a steep decline, company insiders are stepping up to the plate with a series of insider buys, which analysts and experts say is "a strong signal."

Rocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says Analyst

Chardan's Geulah Livshits raises target price for RCKT to $46 and maintains Buy rating after promising data on gene therapy for heart disease.

Andreas Halvorsen Bets On A Healthy Comeback For UnitedHealth

Ole Andreas Halvorsen of Viking Global Investors is betting on UnitedHealth Group, despite the healthcare sector's struggles, suggesting a long-term win.